Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.17 USD | +0.37% | +1.89% | -3.81% |
May. 30 | Sector Update: Health Care Stocks Mixed Late Afternoon | MT |
May. 30 | Catalyst Pharmaceuticals Gets FDA Approval for Dose Increase in LEMS Drug | MT |
Financials (USD)
Sales 2024 * | 462M | Sales 2025 * | 543M | Capitalization | 1.91B |
---|---|---|---|---|---|
Net income 2024 * | 117M | Net income 2025 * | 161M | EV / Sales 2024 * | 3.12 x |
Net cash position 2024 * | 469M | Net cash position 2025 * | 700M | EV / Sales 2025 * | 2.23 x |
P/E ratio 2024 * |
17.2
x | P/E ratio 2025 * |
12.6
x | Employees | 167 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.79% |
Latest transcript on Catalyst Pharmaceuticals, Inc.
1 day | +0.37% | ||
1 week | +1.89% | ||
1 month | +6.38% | ||
3 months | -4.94% | ||
6 months | +9.11% | ||
Current year | -3.81% |
Managers | Title | Age | Since |
---|---|---|---|
Patrick McEnany
FOU | Founder | 76 | 01-12-31 |
Richard Daly
CEO | Chief Executive Officer | 62 | 15-02-18 |
Michael Kalb
DFI | Director of Finance/CFO | 53 | Dec. 31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Patrick McEnany
FOU | Founder | 76 | 01-12-31 |
Donald Denkhaus
BRD | Director/Board Member | 78 | 15-02-18 |
David Tierney
BRD | Director/Board Member | 60 | 02-09-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.05% | 28 M€ | -1.00% | ||
0.32% | 25 M€ | -2.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 16.17 | +0.37% | 666,538 |
24-05-30 | 16.11 | +1.45% | 1,096,467 |
24-05-29 | 15.88 | -4.16% | 839,984 |
24-05-28 | 16.57 | +4.41% | 989,595 |
24-05-24 | 15.87 | -0.31% | 601,635 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.81% | 1.91B | |
-2.29% | 89.87B | |
-3.95% | 37.57B | |
-13.07% | 32.75B | |
+63.05% | 26.47B | |
-22.14% | 14.25B | |
-7.96% | 12.99B | |
-9.33% | 11.93B | |
-46.33% | 10.84B | |
+5.77% | 9.11B |
- Stock Market
- Equities
- CPRX Stock